Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT)

ABSTRACT: Background: Several therapies have been used or proposed for the treatment of COVID-19, although their effectiveness and safety have not been properly evaluated. The purpose of this document is to provide recommendations to support decisions about the drug treatment of outpatients with CO...

Full description

Bibliographic Details

Main Authors:	Maicon Falavigna, Karlyse Claudino Belli, Alexandre Naime Barbosa, Alexandre Prehn Zavascki, Ana Catharina de Seixas Santos Nastri, Christiane Machado Santana, Cinara Stein, Débora Dalmas Gräf, Flavio Adsuara Cadegiani, Hélio Penna Guimarães, José Tadeu Monteiro, Juliana Carvalho Ferreira, Luciano Cesar Pontes de Azevedo, Marcelo Mihailenko Chaves Magri, Marcone Lima Sobreira, Maria Beatriz Gandra de Souza Dias, Maura Salaroli de Oliveira, Mirian de Freitas Dal Ben Corradi, Regis Rosa, Ricardo Souza Heinzelmann, Rosemeri Maurici da Silva, Rubens Belfort Junior, Sergio Cimerman, Verônica Colpani, Viviane Cordeiro Veiga, Carlos Roberto Ribeiro de Carvalho
Format:	Article
Language:	English
Published:	Elsevier 2022-03-01
Series:	Brazilian Journal of Infectious Diseases
Subjects:	COVID-19 COVID-19 drug treatment Guideline SARS-CoV-2 Brazil GRADE
Online Access:	http://www.sciencedirect.com/science/article/pii/S1413867022000356